River Global Investors LLP Has $6.40 Million Position in Henry Schein, Inc. (NASDAQ:HSIC)

River Global Investors LLP trimmed its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 34.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 92,547 shares of the company's stock after selling 47,839 shares during the period. Henry Schein makes up about 1.2% of River Global Investors LLP's investment portfolio, making the stock its 20th biggest position. River Global Investors LLP owned approximately 0.07% of Henry Schein worth $6,404,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also modified their holdings of the company. PNC Financial Services Group Inc. lifted its holdings in Henry Schein by 0.5% during the 4th quarter. PNC Financial Services Group Inc. now owns 86,601 shares of the company's stock worth $5,993,000 after buying an additional 458 shares in the last quarter. Edgestream Partners L.P. raised its position in shares of Henry Schein by 119.5% during the fourth quarter. Edgestream Partners L.P. now owns 10,472 shares of the company's stock worth $725,000 after acquiring an additional 5,702 shares during the last quarter. E Fund Management Co. Ltd. raised its position in shares of Henry Schein by 66.8% during the fourth quarter. E Fund Management Co. Ltd. now owns 4,652 shares of the company's stock worth $322,000 after acquiring an additional 1,863 shares during the last quarter. Raymond James Financial Inc. acquired a new position in shares of Henry Schein during the fourth quarter valued at $34,720,000. Finally, Proficio Capital Partners LLC bought a new position in Henry Schein in the fourth quarter valued at about $943,000. 96.62% of the stock is owned by institutional investors.

Remove Ads

Henry Schein Trading Down 4.1 %

HSIC stock traded down $2.98 during midday trading on Wednesday, hitting $69.94. 1,561,892 shares of the company's stock were exchanged, compared to its average volume of 1,499,705. Henry Schein, Inc. has a one year low of $63.67 and a one year high of $82.49. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The company has a market cap of $8.68 billion, a PE ratio of 28.78, a price-to-earnings-growth ratio of 2.13 and a beta of 0.90. The stock's fifty day moving average price is $74.77 and its 200-day moving average price is $72.64.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. During the same quarter last year, the firm earned $0.66 EPS. The company's revenue for the quarter was up 5.8% on a year-over-year basis. Research analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several brokerages have weighed in on HSIC. Bank of America raised Henry Schein from an "underperform" rating to a "buy" rating and boosted their price objective for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Mizuho began coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They set a "neutral" rating and a $75.00 price target for the company. UBS Group reduced their price objective on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 26th. Wells Fargo & Company assumed coverage on shares of Henry Schein in a research report on Friday, February 14th. They set an "equal weight" rating and a $80.00 target price for the company. Finally, Jefferies Financial Group increased their price target on Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a research note on Thursday, January 23rd. Six equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $81.10.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.